Incorporating Patient Voices from the Start of Drug Development

During Pharma's Almanac's Road to 50 States trans-American trip, Bill McCarthy, Director of Marketing for Excipients and Drug Delivery at SPI Pharma, spoke with Nigel about the importance of incorporating the patients' voice from the very beginning of drug development processes.

Bill McCarthy

Bill McCarthy joined SPI Pharma in 2018 as the Global Marketing Manager for the Excipients and Drug Delivery Systems business unit. He has been the Marketing Director for SPI since 2021. His background includes nearly 20 years in the excipient market with a focus on material science, new application development, and technical promotion. Bill has held roles in operations, technical service, and marketing in the medical device and specialty excipient fields. He brings an understanding of market structure and market-based insights on the value created by SPI Pharma’s product offerings. Bill holds an MBA (International Business) from Loyola University Maryland and a BS in chemical engineering from the University of Notre Dame.

Q: